Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

It comes down to misrepresenting BU:

“ nationwide.

The NBLs and RBLs are operated by the grant recipients, research institutions across the country. These labs support biodefense and emerging infectious diseases research as resources that provide lab space for basic research of dangerous pathogens and development of new vaccines and treatments. The NBLs are required to have BSL-4, BSL-3, and BSL-2 labs, animal facilities, insectary facilities, clinical facilities, and research support space. The RBLs are required to have BSL-3 and BSL-2 labs, animal facilities, and research support space. While fulfilling the need of researchers occupying the facility, the NBLs and RBLs can be used by other biodefense researchers within the region, particularly those within the Regional Centers of Excellence in Biodefense and Emerging Infectious Diseases. In addition, these labs are available to provide assistance to national, state, and local public health efforts during a biological attack.”

BU is a National Biocontainment Center. It is required to have BSL 4 labs, facilities and procedures in place. Regional facilities are not required.

https://fas.org/programs/bio/research.html#NatRegBioconLab